Rebmab200, a Humanized Monoclonal Antibody Targeting the Sodium Phosphate Transporter NaPi2b Displays Strong Immune Mediated Cytotoxicity against Cancer: A Novel Reagent for Targeted Antibody Therapy of Cancer-Reference-Cited by-同舟云学术

Rebmab200, a Humanized Monoclonal Antibody Targeting the Sodium Phosphate Transporter NaPi2b Displays Strong Immune Mediated Cytotoxicity against Cancer: A Novel Reagent for Targeted Antibody Therapy of Cancer

Published:2013-07-31 Issue:7 Volume:8 Page:e70332
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

dos Santos Mariana Lopes,Yeda Fernanda Perez,Tsuruta Lilian Rumi,Horta Bruno Brasil,Pimenta Alécio A.,Degaki Theri Leica,Soares Ibere C.,Tuma Maria Carolina,Okamoto Oswaldo Keith,Alves Venancio A. F.,Old Lloyd J.,Ritter Gerd,Moro Ana Maria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Return to the past: the case for antibody-based therapies in infectious diseases;A Casadevall;Clin Infect Dis,1995

2. Monoclonal antibodies: versatile platforms for cancer immunotherapy;LM Weiner;Nat Rev Immunol,2010

3. Monoclonal antibodies in gynecological cancer: a critical point of view;F Bellati;Clin Dev Immunol,2011

4. Antibody therapy of cancer;AM Scott;Nat Rev Cancer,2012

5. Paul Ehrlich's magic bullet concept: 100 years of progress;K Strebhardt;Nat Rev Cancer,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired proliferation and migration of HUVEC and melanoma cells by human anti-FGF2 mAbs derived from a murine hybridoma by guided selection;Bioengineered;2023-09-04

2. Targeting NaPi2b in ovarian cancer;Cancer Treatment Reviews;2023-01

3. Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn’s-like Lymphoid Reaction;Biomolecules;2022-07-29

4. Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells;Frontiers in Molecular Biosciences;2022-07-15

5. Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases;Biomolecules;2021-12-14